Vita Life Sciences Ltd
ASX:VLS
Prices of ASX stocks are not being updated. The latest VLS price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vita Life Sciences Ltd
ASX:VLS
|
AU |
|
Y
|
Yamaha Motor Co Ltd
XMUN:YMA
|
JP |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
|
Airbus SE
PAR:AIR
|
NL |
|
Scor SE
XETRA:SDRC
|
FR |
|
Roku Inc
NASDAQ:ROKU
|
US |
|
N
|
Norsk Hydro ASA
XMUN:NOH1
|
NO |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
US |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
Acanthe Developpement SE
F:ADX
|
FR |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
E
|
Energy Fuels Inc
F:VO51
|
US |
|
Genasys Inc
NASDAQ:GNSS
|
US |
|
Beam Global
F:16NA
|
US |
|
Stantec Inc
TSX:STN
|
CA |
|
Capstone Copper Corp
OTC:CSCCF
|
CA |
|
C
|
Currency Exchange International Corp
OTC:CURN
|
US |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
Remixpoint Inc
OTC:RPCDF
|
JP |
|
Barry Callebaut AG
SIX:BARN
|
CH |
|
STERIS plc
F:2TG
|
IE |
|
Cytokinetics Inc
NASDAQ:CYTK
|
US |
|
Quang Viet Enterprise Co Ltd
TWSE:4438
|
TW |
Bankruptcy Probability
Vita Life Sciences Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vita Life Sciences Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Vita Life Sciences Ltd
ASX:VLS
|
162.9m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vita Life Sciences Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vita Life Sciences Ltd has total debt of 1.7m AUD. This includes both short-term (0 AUD) and long-term (1.7m AUD) debt.
You can find a full breakdown on its Balance Sheet.